Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 737289, 8 pages
http://dx.doi.org/10.1155/2010/737289
Research Article

Biomolecular Interaction Study of Cyclolinopeptide A with Human Serum Albumin

1Department of Biochemistry, University of Saskatchewan, Saskatoon, SK, Canada S7N 5E5
2Department of Food and Bioproduct Sciences, University of Saskatchewan, Saskatoon, SK, Canada S7N 5A8
3Saskatchewan Structural Sciences Centre, University of Saskatchewan, Saskatoon, SK, Canada S7N 5C9
4Department Plant Sciences, University of Saskatchewan, Saskatoon, SK, Canada S7N 5A8

Received 31 August 2010; Revised 4 December 2010; Accepted 21 December 2010

Academic Editor: Abdel A. Abdel-Rahman

Copyright © 2010 Ben Rempel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. D. Oomah, “Flaxseed as a functional food source,” Journal of the Science of Food and Agriculture, vol. 81, no. 9, pp. 889–894, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. B. D. Oomah and G. Mazza, “Bioactive components of flaxseed: occurrence and health benefits,” 2000. View at Google Scholar
  3. J. Rajesha, K. N. C. Murthy, M. K. Kumar, B. Madhusudhan, and G. A. Ravishankar, “Antioxidant potentials of flaxseed by in vivo model,” Journal of Agricultural and Food Chemistry, vol. 54, no. 11, pp. 3794–3799, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C. M. Bassett, D. Rodriguez-Leyva, and G. N. Pierce, “Experimental and clinical research findings on the cardiovascular benefits of consuming flaxseed,” Applied Physiology, Nutrition and Metabolism, vol. 34, no. 5, pp. 965–974, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. L. Bhatia, A. Sharma, S. Patni, and A. L. Sharma, “Prophylactic effect of flaxseed oil against radiation-induced hepatotoxicity in mice,” Phytotherapy Research, vol. 21, no. 9, pp. 852–859, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Waldschläger, C. Bergemann, W. Ruth et al., “Flax-seed extracts with phytoestrogenic effects on a hormone receptor-positive tumour cell line,” Anticancer Research, vol. 25, no. 3, pp. 1817–1822, 2005. View at Google Scholar · View at Scopus
  7. J. B. Goodnough, “Antitumorigenic effects of flaxseed and its lignan, secoisolariciresinol diglycoside (SDG),” Nutrition Bytes, vol. 10, no. 1, 2005. View at Google Scholar
  8. J. M. Bergman, L. U. Thompson, and C. Dabrosin, “Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo,” Clinical Cancer Research, vol. 13, no. 3, pp. 1061–1067, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Picur, M. Cebrat, J. Zabrocki, and I. Z. Siemion, “Cyclopeptides of Linum usitatissimum,” Journal of Peptide Science, vol. 12, no. 9, pp. 569–574, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. J. Reaney, WO Patent 2009079792.
  11. H. P. Kaufmann and A. Tobschirbel, “An oligopeptide from linseed,” Chemische Berichte, vol. 92, pp. 2805–2809, 1959. View at Google Scholar
  12. Z. Wieczorek, B. Bengtsson, J. Trojnar, and I. Z. Siemion, “Immunosuppressive activity of cyclolinopeptide A,” Peptide Research, vol. 4, no. 5, pp. 275–283, 1991. View at Google Scholar · View at Scopus
  13. T. J. Gaymes, M. Cebrat, I. Z. Siemion, and J. E. Kay, “Cyclolinopeptide A (CLA) mediates its immunosuppressive activity through cyclophilin-dependent calcineurin inactivation,” FEBS Letters, vol. 418, no. 1-2, pp. 224–227, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Bell, P. M. McSteen, M. Cebrat, B. Picur, and I. Z. Siemion, “Antimalarial activity of cyclolinopeptide A and its analogues,” Acta Poloniae Pharmaceutica, vol. 57, pp. 134–136, 2000. View at Google Scholar · View at Scopus
  15. M. R. Ghadiri, J. R. Granja, R. A. Milligan, D. E. McRee, and N. Khazanovich, “Self-assembling organic nanotubes based on a cyclic peptide architecture,” Nature, vol. 366, no. 6453, pp. 324–327, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Temming, M. Lacombe, R. Q. J. Schaapveld et al., “Rational design of RGD-albumin conjugates for targeted delivery of the VEGF-R kinase inhibitor PTK787 to angiogenic endothelium,” ChemMedChem, vol. 1, no. 11, pp. 1200–1203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Ascenzi, A. Bocedi, S. Notari, G. Fanali, R. Fesce, and M. Fasano, “Allosteric modulation of drug binding to human serum albumin,” Mini-Reviews in Medicinal Chemistry, vol. 6, no. 4, pp. 483–489, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Ghuman, P. A. Zunszain, I. Petitpas, A. A. Bhattacharya, M. Otagiri, and S. Curry, “Structural basis of the drug-binding specificity of human serum albumin,” Journal of Molecular Biology, vol. 353, no. 1, pp. 38–52, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. P. W. Atkins, Atkins' Physical Chemistry, W.H. Freeman, New York, NY, USA, 2006.
  20. K. E. van Holde, W. C. Johnson, and P. S. Ho, Principles of Physical Biochemistry, Pearson/Prentice Hall, Upper Saddle River, NJ, USA, 2006.
  21. B. Johnsson, S. Lofas, and G. Lindquist, “Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors,” Analytical Biochemistry, vol. 198, no. 2, pp. 268–277, 1991. View at Google Scholar
  22. G. Bohm, R. Muhr, and R. Jaenicke, “Quantitative analysis of protein far UV circular dichroism spectra by neural networks,” Protein Engineering, vol. 5, no. 3, pp. 191–195, 1992. View at Google Scholar · View at Scopus
  23. H. Aki and M. Yamamoto, “Thermodynamic characterization of drug binding to human serum albumin by isothermal titration microcalorimetry,” Journal of Pharmaceutical Sciences, vol. 83, no. 12, pp. 1712–1716, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Frostell-Karlsson, A. Remaeus, H. Roos et al., “Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels,” Journal of Medicinal Chemistry, vol. 43, no. 10, pp. 1986–1992, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Aki, M. Goto, and M. Yamamoto, “Thermodynamic aspects of the molecular recognition of drugs by human serum albumin,” Thermochimica Acta, vol. 251, pp. 379–388, 1995. View at Google Scholar · View at Scopus
  26. H. Kessler, M. Klein, A. Mueller et al., “Conformational prerequisites for the in vitro inhibition of cholate absorption in hepatocytes by cyclic antamanide and somatostatin analogs,” Angewandte Chemie International Edition, vol. 98, pp. 1030–1032, 1986. View at Google Scholar
  27. E. Benedetti and C. Pedone, “Cyclolinopeptide A: inhibitor, immunosuppressor or other?” Journal of Peptide Science, vol. 11, no. 5, pp. 268–272, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Cebrat, M. Lisowski, I. Z. Siemion, M. Zimecki, and Z. Wieczorek, “Sulfonated analogues of cyclolinopeptide A: synthesis, immunosuppressive activity and CD studies,” Journal of Peptide Research, vol. 49, no. 5, pp. 415–420, 1997. View at Google Scholar · View at Scopus
  29. T. Mannen, S. Yamaguchi, J. Honda, S. Sugimoto, A. Kitayama, and T. Nagamune, “Observation of charge state and conformational change in immobilized protein using surface plasmon resonance sensor,” Analytical Biochemistry, vol. 293, no. 2, pp. 185–193, 2001. View at Publisher · View at Google Scholar · View at Scopus